Posted on 4/23/18
Applied BioMath Announces Collaboration with Checkpoint Therapeutics
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic mathematical modeling, simulation, and analysis to de-risk therapeutic research and development, today announced a collaboration with Checkpoint Therapeutics, . . .
Posted on 4/22/18
Biogen and Ionis Expand Strategic Collaboration
CAMBRIDGE, Mass. & CARLSBAD, Calif.--(BUSINESS WIRE)--Biogen (Nasdaq: BIIB) and Ionis Pharmaceuticals (Nasdaq: IONS) announced today they have expanded their strategic collaboration through a new ten-year collaboration . . .
Posted on 4/19/18
Paratek Pharmaceuticals Prices $140 Million Senior Notes
BOSTON, April 19, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline . . .
Posted on 4/19/18
Surface Oncology Announces $119.5 Million Aggregate Financing
CAMBRIDGE, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- Surface Oncology, Inc. (Nasdaq:SURF), a clinical-stage immuno-oncology company developing next-generation antibody therapies that target the tumor microenvironment, today announced . . .
Posted on 4/18/18
Tufts Medical Center Joins the TriNetX Network for Enhanced Insight into their Clinical Data
Tufts Medical Center (Tufts MC), a 415-bed academic medical center located in downtown Boston, has joined the TriNetX Network to enhance its clinical trial process. Tufts . . .
Posted on 4/18/18
Press Ganey Recognized by Forbes as One of “America’s Best Management Consulting Firms”
BOSTON--(BUSINESS WIRE)--Press Ganey today announced it has been named by Forbes magazine one of “America’s Best Management Consulting Firms.” Press Ganey received this honor based on . . .
Posted on 4/18/18
Paratek Pharmaceuticals Proposes Private Offering of $125 Million Notes
BOSTON, April 18, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline . . .
Posted on 4/18/18
Pfizer Reportedly Rules Out Bristol-Myers Squibb Deal -- Here Are 3 Better Acquisition Targets
So Pfizer (NYSE:PFE) doesn't want to buy Bristol-Myers Squibb (NYSE:BMY) after all? That's what appears to be the case.Pfizer chairman and CEO Ian Read told Citi . . .
Posted on 4/17/18
AMD Global Telemedicine Announces Direct-to-Consumer Telehealth Platform for Healthcare Providers
CHELMSFORD, Mass.--(BUSINESS WIRE)--AMD Global Telemedicine Inc. (AMD), the pioneer of clinical Telemedicine Encounter Management Solutions (TEMS) ®, announces the development of OnDemand Visit, a direct-to-consumer telehealth . . .
Posted on 4/17/18
EyeGate Announces Completion of $11.25 Million Public Offering
WALTHAM, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (Nasdaq:EYEG) , a specialty pharmaceutical company that focuses on developing and commercializing products for treating . . .
Posted on 4/17/18
Novaseek Research and CoxHealth Launch Partnership
CAMBRIDGE, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- Novaseek Research, Inc., a health IT for life sciences company, today launched its partnership with CoxHealth, a health . . .
Posted on 4/16/18
CVS Health Teams Up with Job Corps
In its continuing commitment to expand work-based learning and externship opportunities for students studying to become pharmacy technicians, CVS Health (NYSE: CVS) today announced a new . . .
Posted on 4/16/18
CVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in West Virginia
CVS Health (NYSE: CVS) announced today that the company has expanded its safe medication disposal program to locations inside 19 CVS Pharmacy locations in West Virginia . . .
Posted on 4/16/18
United Neuroscience and Boston University Lee Goldstein Laboratory Form Collaboration
United Neuroscience, Ltd., (UNS), today announced that it has signed a collaboration agreement with the Lee Goldstein laboratory at the Boston University School of Medicine to . . .
Posted on 4/16/18
Applied BioMath Announces Collaboration with Pandion Therapeutics
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling, simulation, and analysis to accelerate and de-risk drug research and development, today announced a collaboration with Pandion . . .
Posted on 4/16/18
Lysogene Reports First Quarter Financial Results and Provides Business Update
CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)--Lysogene (Paris:LYS) (FR0013233475 – LYS), a leading biopharmaceutical company pioneering gene therapy technologies to treat central nervous system (CNS) diseases, today reports . . .
Posted on 4/16/18
Boston Scientific Announces Acquisition Of nVision Medical Corporation
Boston Scientific (NYSE: BSX) today announced that it has acquired nVision Medical Corporation, a privately-held company focused on women's health.
Posted on 4/16/18
SDI Signs Definitive Agreement for Acquisition of New Technology
Security Devices International Inc. announces the signing of a Definitive Agreement with André Buys of South Africa to purchase certain registered
Posted on 4/13/18
EyeGate Announces $11.25 Million Public Offering
WALTHAM, Mass., April 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG), a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for treating diseases and . . .
Posted on 4/11/18
RXi Pharmaceuticals Closes $4.9 Million Registered Direct Offering
MARLBOROUGH, Mass., April 11, 2018 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi (sd-rxRNA®) therapeutic . . .
Posted on 4/11/18
Keryx Biopharmaceuticals Receives 2018 Corporate Innovator Award from the National Kidney Foundation
AUSTIN, Texas, April 11, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today . . .
Posted on 4/11/18
Novartis' Acquisition of AveXis: Bad News for Biogen?
Add another signification biotech acquisition to the list for 2018. After a relatively quiet period for mergers and acquisition in 2017, there has been a flurry . . .
Posted on 4/11/18
Novartis' Acquisition of AveXis Takes Aim at Biogen
Biogen's (NASDAQ:BIIB) Spinraza has been one of the fastest drugs to reach billion-dollar blockbuster territory in recent memory, but its sales could slow as soon as . . .
Posted on 4/10/18
4G Clinical Named One of the 2018 Best Workplaces in Health Care & Biopharma
Great Place to Work and FORTUNE have honored 4G Clinical as one of the 2018 Best Workplaces in Health Care & Biopharma. The ranking considered input . . .
Posted on 4/10/18
Wave Life Sciences and Deep Genomics Form Collaboration to Discover Novel Therapies for Genetic Neuromuscular Disorders
CAMBRIDGE, Mass. and TORONTO, April 10, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with . . .

